APO Research
Talk to an analyst

APO RESEARCH · REPORT

Posterior Pituitary Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Posterior Pituitary Injection Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchPosterior Pituitary Injection Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Posterior Pituitary Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Posterior Pituitary Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Posterior Pituitary Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Posterior Pituitary Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Posterior Pituitary Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Posterior Pituitary Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Posterior Pituitary Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Posterior Pituitary Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Posterior Pituitary Injection include Eisai (Liaoning) Pharmaceutical, Shanghai No. 1 Biochemical & Pharmaceutical, Shanghai Harvest Pharmaceutical, Nanjing Xinbai Pharmaceutical, Kamp Pharmaceutical, Chengdu Hepatunn Pharmaceutical, Beijing Science Sun and Anhui Hongye Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Posterior Pituitary Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Posterior Pituitary Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Posterior Pituitary Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Posterior Pituitary Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Posterior Pituitary Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Posterior Pituitary Injection Market by Company

Eisai (Liaoning) Pharmaceutical

Shanghai No. 1 Biochemical & Pharmaceutical

Shanghai Harvest Pharmaceutical

Nanjing Xinbai Pharmaceutical

Kamp Pharmaceutical

Chengdu Hepatunn Pharmaceutical

Beijing Science Sun

Anhui Hongye Pharmaceutical

Posterior Pituitary Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Posterior Pituitary Injection Segment by Application

Obstetric Oxytocia

Lung or Bronchi Bleeding

Gastrointestinal Bleeding

Others

Posterior Pituitary Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Posterior Pituitary Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Posterior Pituitary Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Posterior Pituitary Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Posterior Pituitary Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Posterior Pituitary Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intramuscular Injection Table 2. Major Company of Intravenous Drip Table 3. Global Posterior Pituitary Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Posterior Pituitary Injection Sales by Type (2021-2026) & (k units) Table 5. Global Posterior Pituitary Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Posterior Pituitary Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Posterior Pituitary Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Posterior Pituitary Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Posterior Pituitary Injection Sales by Type (2027-2032) & (k units) Table 10. Global Posterior Pituitary Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Posterior Pituitary Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Posterior Pituitary Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Posterior Pituitary Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Posterior Pituitary Injection Sales by Type (2021-2026) & (k units) Table 15. North America Posterior Pituitary Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Posterior Pituitary Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Posterior Pituitary Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Posterior Pituitary Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Posterior Pituitary Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Posterior Pituitary Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Posterior Pituitary Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Posterior Pituitary Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Posterior Pituitary Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Posterior Pituitary Injection Industry Trends Table 25. Posterior Pituitary Injection Industry Drivers Table 26. Posterior Pituitary Injection Industry Opportunities and Challenges Table 27. Posterior Pituitary Injection Industry Restraints Table 28. Global Posterior Pituitary Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Posterior Pituitary Injection Revenue Market Share by Company (2021-2026) Table 30. Global Posterior Pituitary Injection Sales by Company (2021-2026) & (k units) Table 31. Global Posterior Pituitary Injection Sales Share by Company (2021-2026) Table 32. Global Posterior Pituitary Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Posterior Pituitary Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Posterior Pituitary Injection Major Company Production Sites and Headquarters Table 35. Global Posterior Pituitary Injection Company, Product Type & Application Table 36. Global Posterior Pituitary Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Posterior Pituitary Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Posterior Pituitary Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Posterior Pituitary Injection Sales by Region (2021-2026) & (k units) Table 41. Global Posterior Pituitary Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Posterior Pituitary Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Posterior Pituitary Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Posterior Pituitary Injection Sales by Region (2027-2032) & (k units) Table 46. Global Posterior Pituitary Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Posterior Pituitary Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Posterior Pituitary Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Posterior Pituitary Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Posterior Pituitary Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Posterior Pituitary Injection Sales by Application (2021-2026) & (k units) Table 52. Global Posterior Pituitary Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Posterior Pituitary Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Posterior Pituitary Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Posterior Pituitary Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Posterior Pituitary Injection Sales by Application (2027-2032) & (k units) Table 57. Global Posterior Pituitary Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Posterior Pituitary Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Posterior Pituitary Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Posterior Pituitary Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Posterior Pituitary Injection Sales by Application (2021-2026) & (k units) Table 62. North America Posterior Pituitary Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Posterior Pituitary Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Posterior Pituitary Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Posterior Pituitary Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Posterior Pituitary Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Posterior Pituitary Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Posterior Pituitary Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Posterior Pituitary Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Posterior Pituitary Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Eisai (Liaoning) Pharmaceutical Company Information Table 72. Eisai (Liaoning) Pharmaceutical Business Overview Table 73. Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 75. Eisai (Liaoning) Pharmaceutical Recent Development Table 76. Shanghai No. 1 Biochemical & Pharmaceutical Company Information Table 77. Shanghai No. 1 Biochemical & Pharmaceutical Business Overview Table 78. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 80. Shanghai No. 1 Biochemical & Pharmaceutical Recent Development Table 81. Shanghai Harvest Pharmaceutical Company Information Table 82. Shanghai Harvest Pharmaceutical Business Overview Table 83. Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 85. Shanghai Harvest Pharmaceutical Recent Development Table 86. Nanjing Xinbai Pharmaceutical Company Information Table 87. Nanjing Xinbai Pharmaceutical Business Overview Table 88. Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 90. Nanjing Xinbai Pharmaceutical Recent Development Table 91. Kamp Pharmaceutical Company Information Table 92. Kamp Pharmaceutical Business Overview Table 93. Kamp Pharmaceutical Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Kamp Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 95. Kamp Pharmaceutical Recent Development Table 96. Chengdu Hepatunn Pharmaceutical Company Information Table 97. Chengdu Hepatunn Pharmaceutical Business Overview Table 98. Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 100. Chengdu Hepatunn Pharmaceutical Recent Development Table 101. Beijing Science Sun Company Information Table 102. Beijing Science Sun Business Overview Table 103. Beijing Science Sun Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Beijing Science Sun Posterior Pituitary Injection Product Portfolio Table 105. Beijing Science Sun Recent Development Table 106. Anhui Hongye Pharmaceutical Company Information Table 107. Anhui Hongye Pharmaceutical Business Overview Table 108. Anhui Hongye Pharmaceutical Posterior Pituitary Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Anhui Hongye Pharmaceutical Posterior Pituitary Injection Product Portfolio Table 110. Anhui Hongye Pharmaceutical Recent Development Table 111. North America Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. North America Posterior Pituitary Injection Sales by Country (2021-2026) & (k units) Table 113. North America Posterior Pituitary Injection Sales Market Share by Country (2021-2026) Table 114. North America Posterior Pituitary Injection Sales Forecast by Country (2027-2032) & (k units) Table 115. North America Posterior Pituitary Injection Sales Market Share Forecast by Country (2027-2032) Table 116. North America Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Posterior Pituitary Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Posterior Pituitary Injection Market Share by Country (2021-2026) Table 119. North America Posterior Pituitary Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Posterior Pituitary Injection Market Share Forecast by Country (2027-2032) Table 121. Europe Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Europe Posterior Pituitary Injection Sales by Country (2021-2026) & (k units) Table 123. Europe Posterior Pituitary Injection Sales Market Share by Country (2021-2026) Table 124. Europe Posterior Pituitary Injection Sales Forecast by Country (2027-2032) & (k units) Table 125. Europe Posterior Pituitary Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Posterior Pituitary Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Posterior Pituitary Injection Market Share by Country (2021-2026) Table 129. Europe Posterior Pituitary Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Posterior Pituitary Injection Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Posterior Pituitary Injection Sales by Country (2021-2026) & (k units) Table 133. Asia-Pacific Posterior Pituitary Injection Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Posterior Pituitary Injection Sales Forecast by Country (2027-2032) & (k units) Table 135. Asia-Pacific Posterior Pituitary Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Posterior Pituitary Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Posterior Pituitary Injection Market Share by Country (2021-2026) Table 139. Asia-Pacific Posterior Pituitary Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Posterior Pituitary Injection Market Share Forecast by Country (2027-2032) Table 141. Latin America Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Latin America Posterior Pituitary Injection Sales by Country (2021-2026) & (k units) Table 143. Latin America Posterior Pituitary Injection Sales Market Share by Country (2021-2026) Table 144. Latin America Posterior Pituitary Injection Sales Forecast by Country (2027-2032) & (k units) Table 145. Latin America Posterior Pituitary Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Posterior Pituitary Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Posterior Pituitary Injection Market Share by Country (2021-2026) Table 149. Latin America Posterior Pituitary Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Posterior Pituitary Injection Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Posterior Pituitary Injection Sales by Country (2021-2026) & (k units) Table 153. Middle East and Africa Posterior Pituitary Injection Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Posterior Pituitary Injection Sales Forecast by Country (2027-2032) & (k units) Table 155. Middle East and Africa Posterior Pituitary Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Posterior Pituitary Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Posterior Pituitary Injection Market Share by Country (2021-2026) Table 159. Middle East and Africa Posterior Pituitary Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Posterior Pituitary Injection Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Posterior Pituitary Injection Distributors List Table 164. Posterior Pituitary Injection Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Posterior Pituitary Injection Image Figure 2. Global Posterior Pituitary Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Posterior Pituitary Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Posterior Pituitary Injection Sales (2021-2032) & (k units) Figure 5. Intramuscular Injection Image Figure 6. Global Intramuscular Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. Intravenous Drip Image Figure 8. Global Intravenous Drip Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Posterior Pituitary Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Posterior Pituitary Injection Market Share by Type 2025 VS 2032 Figure 11. North America Posterior Pituitary Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Posterior Pituitary Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Posterior Pituitary Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Posterior Pituitary Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Posterior Pituitary Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Posterior Pituitary Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Posterior Pituitary Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Posterior Pituitary Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Posterior Pituitary Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Posterior Pituitary Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Posterior Pituitary Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Obstetric Oxytocia Image Figure 24. Global Obstetric Oxytocia Sales YoY Growth (2021-2032) & (k units) Figure 25. Lung or Bronchi Bleeding Image Figure 26. Global Lung or Bronchi Bleeding Sales YoY Growth (2021-2032) & (k units) Figure 27. Gastrointestinal Bleeding Image Figure 28. Global Gastrointestinal Bleeding Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Posterior Pituitary Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Posterior Pituitary Injection Market Share by Application 2025 VS 2032 Figure 33. North America Posterior Pituitary Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Posterior Pituitary Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Posterior Pituitary Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Posterior Pituitary Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Posterior Pituitary Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Posterior Pituitary Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Posterior Pituitary Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Posterior Pituitary Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Posterior Pituitary Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Posterior Pituitary Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Posterior Pituitary Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Posterior Pituitary Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Posterior Pituitary Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Posterior Pituitary Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Posterior Pituitary Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Posterior Pituitary Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Posterior Pituitary Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Posterior Pituitary Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Posterior Pituitary Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Posterior Pituitary Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Posterior Pituitary Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Posterior Pituitary Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Posterior Pituitary Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Posterior Pituitary Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Posterior Pituitary Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Posterior Pituitary Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Posterior Pituitary Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Obstetric Oxytocia
  • Lung or Bronchi Bleeding
  • Gastrointestinal Bleeding
  • Others
Companies covered
  • Eisai (Liaoning) Pharmaceutical
  • Shanghai No. 1 Biochemical & Pharmaceutical
  • Shanghai Harvest Pharmaceutical
  • Nanjing Xinbai Pharmaceutical
  • Kamp Pharmaceutical
  • Chengdu Hepatunn Pharmaceutical
  • Beijing Science Sun
  • Anhui Hongye Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Posterior Pituitary Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Posterior Pituitary Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Posterior Pituitary Injection Market by Type
  6. 1.3.1 Intramuscular Injection
  7. 1.3.2 Intravenous Drip
  8. 1.4 Global Posterior Pituitary Injection Market Size by Type
  9. 1.4.1 Global Posterior Pituitary Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Posterior Pituitary Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Posterior Pituitary Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Posterior Pituitary Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Posterior Pituitary Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Posterior Pituitary Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Posterior Pituitary Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Posterior Pituitary Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Posterior Pituitary Injection Industry Trends
  2. 2.2 Posterior Pituitary Injection Industry Drivers
  3. 2.3 Posterior Pituitary Injection Industry Opportunities and Challenges
  4. 2.4 Posterior Pituitary Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Posterior Pituitary Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Posterior Pituitary Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Posterior Pituitary Injection Price (2021-2026)
  4. 3.4 Global Posterior Pituitary Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Posterior Pituitary Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Posterior Pituitary Injection Company, Product Type & Application
  7. 3.7 Global Posterior Pituitary Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Posterior Pituitary Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Posterior Pituitary Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Posterior Pituitary Injection Tier 1, Tier 2, and Tier 3
4 Posterior Pituitary Injection Regional Status and Outlook
  1. 4.1 Global Posterior Pituitary Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Posterior Pituitary Injection Historic Market Size by Region
  3. 4.2.1 Global Posterior Pituitary Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Posterior Pituitary Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Posterior Pituitary Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Posterior Pituitary Injection Forecasted Market Size by Region
  7. 4.3.1 Global Posterior Pituitary Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Posterior Pituitary Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Posterior Pituitary Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Posterior Pituitary Injection by Application
  1. 5.1 Posterior Pituitary Injection Market by Application
  2. 5.1.1 Obstetric Oxytocia
  3. 5.1.2 Lung or Bronchi Bleeding
  4. 5.1.3 Gastrointestinal Bleeding
  5. 5.1.4 Others
  6. 5.2 Global Posterior Pituitary Injection Market Size by Application
  7. 5.2.1 Global Posterior Pituitary Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Posterior Pituitary Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Posterior Pituitary Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Posterior Pituitary Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Posterior Pituitary Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Posterior Pituitary Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Posterior Pituitary Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Posterior Pituitary Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai (Liaoning) Pharmaceutical
  2. 6.1.1 Eisai (Liaoning) Pharmaceutical Company Information
  3. 6.1.2 Eisai (Liaoning) Pharmaceutical Business Overview
  4. 6.1.3 Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Product Portfolio
  6. 6.1.5 Eisai (Liaoning) Pharmaceutical Recent Developments
  7. 6.2 Shanghai No. 1 Biochemical & Pharmaceutical
  8. 6.2.1 Shanghai No. 1 Biochemical & Pharmaceutical Company Information
  9. 6.2.2 Shanghai No. 1 Biochemical & Pharmaceutical Business Overview
  10. 6.2.3 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Product Portfolio
  12. 6.2.5 Shanghai No. 1 Biochemical & Pharmaceutical Recent Developments
  13. 6.3 Shanghai Harvest Pharmaceutical
  14. 6.3.1 Shanghai Harvest Pharmaceutical Company Information
  15. 6.3.2 Shanghai Harvest Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Product Portfolio
  18. 6.3.5 Shanghai Harvest Pharmaceutical Recent Developments
  19. 6.4 Nanjing Xinbai Pharmaceutical
  20. 6.4.1 Nanjing Xinbai Pharmaceutical Company Information
  21. 6.4.2 Nanjing Xinbai Pharmaceutical Business Overview
  22. 6.4.3 Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Product Portfolio
  24. 6.4.5 Nanjing Xinbai Pharmaceutical Recent Developments
  25. 6.5 Kamp Pharmaceutical
  26. 6.5.1 Kamp Pharmaceutical Company Information
  27. 6.5.2 Kamp Pharmaceutical Business Overview
  28. 6.5.3 Kamp Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kamp Pharmaceutical Posterior Pituitary Injection Product Portfolio
  30. 6.5.5 Kamp Pharmaceutical Recent Developments
  31. 6.6 Chengdu Hepatunn Pharmaceutical
  32. 6.6.1 Chengdu Hepatunn Pharmaceutical Company Information
  33. 6.6.2 Chengdu Hepatunn Pharmaceutical Business Overview
  34. 6.6.3 Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Product Portfolio
  36. 6.6.5 Chengdu Hepatunn Pharmaceutical Recent Developments
  37. 6.7 Beijing Science Sun
  38. 6.7.1 Beijing Science Sun Company Information
  39. 6.7.2 Beijing Science Sun Business Overview
  40. 6.7.3 Beijing Science Sun Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Science Sun Posterior Pituitary Injection Product Portfolio
  42. 6.7.5 Beijing Science Sun Recent Developments
  43. 6.8 Anhui Hongye Pharmaceutical
  44. 6.8.1 Anhui Hongye Pharmaceutical Company Information
  45. 6.8.2 Anhui Hongye Pharmaceutical Business Overview
  46. 6.8.3 Anhui Hongye Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Anhui Hongye Pharmaceutical Posterior Pituitary Injection Product Portfolio
  48. 6.8.5 Anhui Hongye Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Posterior Pituitary Injection Sales by Country
  2. 7.1.1 North America Posterior Pituitary Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Posterior Pituitary Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Posterior Pituitary Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Posterior Pituitary Injection Market Size by Country
  6. 7.2.1 North America Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Posterior Pituitary Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Posterior Pituitary Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Posterior Pituitary Injection Sales by Country
  2. 8.1.1 Europe Posterior Pituitary Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Posterior Pituitary Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Posterior Pituitary Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Posterior Pituitary Injection Market Size by Country
  6. 8.2.1 Europe Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Posterior Pituitary Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Posterior Pituitary Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Posterior Pituitary Injection Sales by Country
  2. 9.1.1 Asia-Pacific Posterior Pituitary Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Posterior Pituitary Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Posterior Pituitary Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Posterior Pituitary Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Posterior Pituitary Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Posterior Pituitary Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Posterior Pituitary Injection Sales by Country
  2. 10.1.1 South America Posterior Pituitary Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Posterior Pituitary Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Posterior Pituitary Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Posterior Pituitary Injection Market Size by Country
  6. 10.2.1 South America Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Posterior Pituitary Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Posterior Pituitary Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Posterior Pituitary Injection Sales by Country
  2. 11.1.1 Middle East and Africa Posterior Pituitary Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Posterior Pituitary Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Posterior Pituitary Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Posterior Pituitary Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Posterior Pituitary Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Posterior Pituitary Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Posterior Pituitary Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Posterior Pituitary Injection Value Chain Analysis
  2. 12.1.1 Posterior Pituitary Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Posterior Pituitary Injection Production Mode & Process
  7. 12.2 Posterior Pituitary Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Posterior Pituitary Injection Distributors
  10. 12.2.3 Posterior Pituitary Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst